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The software solution “Imunolog”, presented in this paper, is developed after winning 
international project between University Hospital Alexandrovska, New Bulgarian University 
and Barcelona Medical University. 
The fundamental initiative is to localize the main predispositions for this disease based 
on the statistic data from Bulgarian patients, the relationship between treatment and following 
manifestations of the disease, sequence of results from a concrete therapy and human body 
systems reactions and adaptation.  
In our country there are no investigations and results, regardless of the enormous 
database of paper epicrysis, visits and anamnesis.  
Systemic lupus erythematosus (SLE) is a widespread disease with unknown cause, 
which attacks person's immune system and injures the body's own organs and tissues.  
We have addressed this problem and devised a software system for assessing both 
current lupus disease activity and changes in that activity since the patient`s last visit. 
Imunolog©® is retrospective database with strictly defined purpose objectives – to explore 
causes, treatment schemes, manifestations and reactions of all available patients in Bulgaria 
since 1960. It is a result of won international project between University Hospital 
Alexandrovska, New Bulgarian University and Barcelona Medical University.  
Studies of the natural history of the disease and the effect of therapeutic intervention 
have been hampered by the lack of a satisfactory method of assessing disease activity. In 
particular there is no good way of evaluating changes in disease activity which could be used 
to compare studies from different centres.  
Imunolog©® is organized collection, for storage and presentation of medical data and 
other knowledge for decision making, progress reporting, and for planning and evaluation of 
programs.  
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Figure 1 American Rheumatism Association developed 
symptoms for diagnosong SLE in MIS “Imunolog” 
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? General Manifestations of SLE  
Figure 2 Manifestations screen of Imunolog 
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Each of them is in details described in Imunolog - Figure 2 Manifestations screen of 
Imunolog. 
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Whenever entered any data can be edited, again written or deleted. Only in the cases 
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Conclusion 
 increased communication between medical experts from different countries;  
formation for patients at every language. 
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For the Bulgarian medical institutions this is the first specific immunological database 
with retrospective entered data.  
Our purpose is to ensure statistical background on the one hand for researching and on 
the other – complete information for the population. 
The advances in medical care, genetic tests and development of software database for 
precise statistics and research would make possible to cure and even to prevent from these 
fatal disease. 
The successful treatment schemes of Lupus depends on: 
? increased information for new technological, software and research methods;  
?
? increased in
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